AnteoTech (ASX:ADO) to receive $1.2M tax refund
27 Nov 2020 - AnteoTech (ASX:ADO) has received a tax refund of almost $1.2 million under the Federal Government’s Research & Development Tax Incentive Scheme.
30Nov
30Nov
AnteoTech (ASX:ADO) to receive $1.2M tax refund
27 Nov 2020 - AnteoTech (ASX:ADO) has received a tax refund of almost $1.2 million under the Federal Government’s Research & Development Tax Incentive Scheme.
30Nov
Unexpected resignation of Oil Search’s (ASX:OSH) CFO hire
27 Nov 2020 - Oil Search’s (ASX:OSH) Chief Financial Officer Designate, Ayten Saridas has resigned from her position.
27Nov
AnteoTech (ASX:ADO) to receive $1.2M tax refund
27 Nov 2020 - AnteoTech (ASX:ADO) has received a tax refund of almost $1.2 million under the Federal Government’s Research & Development Tax Incentive Scheme.
27Nov
Holista Colltech (ASX:HCT) application to advertise effectiveness in killing Covid 19
27 Nov 2020 - Natural wellness company, Holista Colltech (ASX:HCT) has commissioned an application to allow its NatShieldTM and ProtecteneTM range of products to be labelled as effective in killing the Covid 19 virus.
27Nov
Unexpected resignation of Oil Search’s (ASX:OSH) CFO hire
27 Nov 2020 - Oil Search’s (ASX:OSH) Chief Financial Officer Designate, Ayten Saridas has resigned from her position.
27Nov
Genesis (ASX:GNE) launches strategic review of Kupe holding
27 Nov 2020 - New Zealand energy company, Genesis Energy (ASX:GNE) today announces that it is undertaking a strategic review to determine whether to sell or retain its interest in Kupe.
27Nov
Spark New Zealand (ASX:SPK) subsidiary extends credit facility
27 Nov 2020 - A subsidiary of Spark New Zealand (ASX:SPK), has extended the term of its revolving credit facility with Westpac New Zealand.
26Nov
Bega Cheese (ASX:BGA) to buy Lion Dairy & Drink for $534m
26 Nov 2020 - Bega Cheese (ASX:BGA) has entered into a binding agreement to acquire Lion Dairy & Drinks Pty for $534 million.
26Nov
Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded over $17 million
26 Nov 2020 - Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded over $17 million of Synthetic Antibiotic Research & Development applicable expenditure by AusIndustry.